We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > biosimilar market

News List

Informing payers and patients of biological therapy advantages can strengthen biosimilars market expresspharma
September 23, 2020
Patients are unaware of the cost savings and payers are unclear if they can replace the reference biologics with the biosimilar drugs, says a GlobalData report.
FDA chief Gottlieb blames drugmakers for ‘anemic’ biosimilar market fiercepharma
July 23, 2018
The FDA has so far approved 11 biosimilars, drugs that should be saving patients billions of dollars. But so far, only three of the 11 have made it to the market in the U.S., a fact FDA Commissioner Scott Gottlieb, M.D., is blaming on the reference drugma
Indian biosimilar market likely to touch $1 billion in three years firstwordpharma
February 20, 2017
According to industry estimates, India's biosimilars market could exceed $1 billion by 2020, as reported Business Standard Sunday.